SG11202012015YA - Compositions and methods for the modulation of adaptive immunity - Google Patents

Compositions and methods for the modulation of adaptive immunity

Info

Publication number
SG11202012015YA
SG11202012015YA SG11202012015YA SG11202012015YA SG11202012015YA SG 11202012015Y A SG11202012015Y A SG 11202012015YA SG 11202012015Y A SG11202012015Y A SG 11202012015YA SG 11202012015Y A SG11202012015Y A SG 11202012015YA SG 11202012015Y A SG11202012015Y A SG 11202012015YA
Authority
SG
Singapore
Prior art keywords
modulation
compositions
methods
adaptive immunity
immunity
Prior art date
Application number
SG11202012015YA
Inventor
David A Nelles
Ranjan Batra
Eugene Yeo
Original Assignee
Locanabio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Locanabio Inc filed Critical Locanabio Inc
Publication of SG11202012015YA publication Critical patent/SG11202012015YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
SG11202012015YA 2018-06-08 2019-06-07 Compositions and methods for the modulation of adaptive immunity SG11202012015YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862682276P 2018-06-08 2018-06-08
PCT/US2019/036050 WO2019236998A1 (en) 2018-06-08 2019-06-07 Compositions and methods for the modulation of adaptive immunity

Publications (1)

Publication Number Publication Date
SG11202012015YA true SG11202012015YA (en) 2021-01-28

Family

ID=68769461

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012015YA SG11202012015YA (en) 2018-06-08 2019-06-07 Compositions and methods for the modulation of adaptive immunity

Country Status (9)

Country Link
US (1) US20190382759A1 (en)
EP (1) EP3801641A4 (en)
JP (1) JP2021526860A (en)
KR (1) KR20210060429A (en)
CN (1) CN113286619A (en)
AU (1) AU2019281006A1 (en)
CA (1) CA3102783A1 (en)
SG (1) SG11202012015YA (en)
WO (1) WO2019236998A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3765094A4 (en) 2018-03-15 2021-12-22 KSQ Therapeutics, Inc. Gene-regulating compositions and methods for improved immunotherapy
WO2019236982A1 (en) 2018-06-08 2019-12-12 Locana, Inc. Rna-targeting fusion protein compositions and methods for use
MX2021008487A (en) * 2019-01-14 2021-11-12 Univ Rochester Targeted nuclear rna cleavage and polyadenylation with crispr-cas.
US11661459B2 (en) 2020-12-03 2023-05-30 Century Therapeutics, Inc. Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
WO2023150131A1 (en) * 2022-02-01 2023-08-10 The Regents Of The University Of California Method of regulating alternative polyadenylation in rna
CN114848808B (en) * 2022-03-24 2023-04-25 四川大学 Immunopotentiator based on cationic lipopolypeptide and cytokine, and preparation method and application thereof
CN116949011A (en) * 2022-04-26 2023-10-27 中国科学院动物研究所 Isolated Cas13 protein, gene editing system based on same and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019500899A (en) * 2015-11-23 2019-01-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Cellular RNA tracking and manipulation through nuclear delivery of CRISPR / Cas9
US20180362975A1 (en) * 2015-12-04 2018-12-20 Novartis Ag Compositions and methods for immunooncology
US20210285010A1 (en) * 2016-10-31 2021-09-16 University Of Florida Research Foundation, Inc. Compositions and methods for impeding transcription of expanded microsatellite repeats
KR102185464B1 (en) * 2017-03-15 2020-12-03 매사추세츠 인스티튜트 오브 테크놀로지 New CAS13B Ortholog CRISPR Enzyme and System
US10392616B2 (en) * 2017-06-30 2019-08-27 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof

Also Published As

Publication number Publication date
KR20210060429A (en) 2021-05-26
CA3102783A1 (en) 2019-12-12
EP3801641A1 (en) 2021-04-14
EP3801641A4 (en) 2022-09-28
CN113286619A (en) 2021-08-20
JP2021526860A (en) 2021-10-11
WO2019236998A1 (en) 2019-12-12
AU2019281006A1 (en) 2021-01-28
US20190382759A1 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
IL277079A (en) Cartyrin compositions and methods for use
SG11202012015YA (en) Compositions and methods for the modulation of adaptive immunity
IL280134A (en) Anti-cd112r compositions and methods
EP3589646A4 (en) Cd19 compositions and methods for immunotherapy
IL268970A (en) Novel compositions and methods
GB202201859D0 (en) Novel methods and compositions
WO2015120138A3 (en) AGENTS THAT MODULATE RGMb-NEOGENIN-BMP SIGNALING AND METHODS OF USE THEREOF
IL266562A (en) Methods and compositions for adaptive immune modulation
IL281015A (en) Methods and compositions for the modification of plants
ZA202101362B (en) Compositions and methods for treating the eye
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
SG11202104448WA (en) Compositions and methods
ZA202101342B (en) Compositions and methods for treating the eye
EP3844500A4 (en) Rp182 compositions and methods
GB201815402D0 (en) Compositions and methods and uses relating thereto
GB2578519B (en) Compositions and methods and uses relating thereto
IL283850A (en) Cannabis compositions and methods
GB201817444D0 (en) Methods and compositions
IL264977A (en) Methods and compositions for the treatment of melanoma
ZA202101360B (en) Compositions and methods for treating the eye
ZA202101361B (en) Compositions and methods for treating the eye
GB201819987D0 (en) Methods and compositions
IL273699A (en) Sulfasalazine salt compositions and methods of using the same
EP3628009A4 (en) Compositions and methods for improving cognition
IL281835A (en) Anti-malaria compositions and methods